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We compared the levels of latent pseudorabies virus (PRV) DNA in trigeminal ganglia (TG) of pigs after
intranasal inoculation of different PRV strains by using quantitative DNA PCR. The extent of colonization
attained in each case varied significantly according to the type of strain and inoculum dose, wild-type (WT)
PRV being the most efficient strain in colonizing TG. When groups of pigs representing different levels of
precolonization of TG with an attenuated PRV strain were challenged with WT PRV, it became evident that
there is a statistically significant inverse correlation between the extent of precolonization attained by an
attenuated PRV strain in TG and the level of establishment of latency by superinfecting WT PRV. The protection against WT PRV latency did not correlate with the extent of WE PRV replication at the portal of entry.

attenuated alphaherpesvirus strains could significantly reduce
WT virus latency (9).
We developed a quantitative and differential PRV-specific
PCR (29). Using this technique, we show in this report that
there is a range of variability among PRV strains in the ability
to precolonize trigeminal ganglia (TG) and that a significant
correlation exists between the level of latency established by a
vaccine strain and the level of protection from latency established by superinfecting WT virus.
For the quantitation of DNA in TG, the entire left and right
TG of each animal were combined and processed for total
DNA extraction as previously described (5). The quantitative
PCR technique has been described elsewhere (29). Briefly, up
to 2 ,ug of DNA, extracted by standard techniques, was
amplified in 100 ,ul of Taq polymerase buffer (50 mM KCl, 10
mM Tris * Cl [pH 9], 0.1% Triton X-100, 1.5 mM MgCl)
containing 0.200 mM each deoxynucleoside triphosphate,
0.200 mM each PRV-specific primer, 0.080 mM each standardspecific primer, and 5 U of Taq polymerase. Amplification was
carried out for 40 cycles (each cycle comprised 1 min at 95°C
for denaturation, 1 min at 65°C for annealing, and from 3 min
[first cycle] to 4 min 20 s [last cycle] at 72°C for extension).
After the last cycle, the reaction mixture was further incubated
at 72°C for 7 min, to allow the complete extension of all the
amplified products.
The targets for amplification, primers, and probe sequences
were as follows. For detection of WT virus in pigs infected with
both the WT and vaccine strains, the target for amplification
was the gene that codes for the nonessential glycoprotein gI.
(According to the common nomenclature for alphaherpesvirus
glycoproteins agreed upon at the 1993 International Herpesvirus Workshop, the denominations gI, gp63, gX, and gpSO,
used in this report to name PRV glycoproteins, should be
replaced in the future by the denominations gE, gI, gG, and
gD, respectively.) Since all the vaccine strains used in the
challenge study were gI deleted, these primers would detect
and quantitate only superinfecting WT virus. The upstream
primer was CCCACGCACGAGGACTACTAC, the downstream primer was CGCGGAACCAGACGTCGAAGC, the
amplified sequence was from positions 2673 to 2884 (num-

A common characteristic of all members of the subfamily
Alphaherpesvirinae, including pseudorabies virus (PRV), is the
ability to establish latency in sensory neurons following an
acute infection (27). In the latent state, the virus does not
produce clinical symptoms but it persists indefinitely in the
infected individual (9, 25, 27). After specific stimulation, the
latent virus can be reactivated and shed to the environment,
thus infecting susceptible individuals (1, 9, 18, 25). In some
cases, it can also produce recrudescence of clinical disease (9,
25, 27). Latency is, then, very important from an epidemiological standpoint because it is the mechanism by which alpha-

herpesviruses persist in populations of susceptible individuals

(1, 25, 27).

Protection against the latent state of alphaherpesvirus infection has always been a major goal for the development of
specific vaccines (15, 26). For PRV, classically attenuated or
genetically engineered, modified live vaccines have been used
successfully for many years to minimize both clinical symptoms
and viral shedding during the acute phase of the infection (33).
However, little is known about their influence on the latent
phase of the infection (1, 18, 33).
In studies using animal models of herpes simplex virus
infections, it has been reported that the establishment of
latency in a target tissue by a preceding viral strain precludes
the colonization of the same tissue by another strain (3, 10, 16,
32). Epidemiological studies of human infections have suggested that this restriction also exists under natural conditions
(13). Subsequently, it was reported that this restriction would
not be absolute for herpes simplex virus (11) or bovine
herpesvirus 1 (35). Even if a total impairment of wild-type
(WT) alphaherpesvirus latency cannot be accomplished, it is
possible that the precolonization of latency target tissues by
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bered as in reference 20), and the probe for hybridization was
ACGCCCGCCGGCGGCCCT. For detection of vaccine virus
in the vaccinated, nonchallenged animals, the target of amplification was the gene that codes for the essential glycoprotein
gp5O. The upstream primer was CACGGAGGACGAGCTGG
GGCT, the downstream primer was GTCCACGCCCCGCTIl
GAAGCT, the amplified sequence was from positions 434 to
650 (numbered as in reference 19), and the probe for hybridization was CGCCTGGTGTCCGTCGACGGCGTGAACA
TC. As the standard used to measure the efficiency of amplification in the different samples, the target of amplification was
the gene that codes for the porcine nuclear factor 1 (NF1). The
upstream primer was GCTGCGTGCTCTCCAACCCCG, the
downstream primer was CCCCGCCTCACCTCGCTCG, the
amplified sequence was from positions 900 to 1165 (numbered
as in reference 17), and the probe for hybridization was CTC
GCCGTCGGTGCTCTCCAGCGGGATGC.
The concentration of DNA determined by the quantitative
PCR is a relative estimate expressed as viral copies per cell
equivalent, assuming that 2 x 106 cells contain approximately
1 ,ug of pig genomic DNA.
The samples that were negative by the quantitative assay
were run as a standard PCR, with the amount of input DNA
increased. Briefly, up to 5 ,ug of DNA was amplified under the
same conditions as those used for the quantitative assay, but
omitting the NFl primers and using only 0.100 mM each PRV
primer (specific for either the gI or the gpSO gene) and 2.5 U
of Taq polymerase. In this way, the amount of viral DNA can
be estimated even when present at very low levels (up to one
viral copy in 5 jxg of total DNA).
The PCR-amplified products were electrophoresed and analyzed by Southern blot hybridization. The amount of radioactivity hybridized to virus-specific and standard-specific amplified products was evaluated by using an Ambys image
analyzer. A titration in which logarithmic dilutions of viral
DNA were added to a constant amount of PRV-free pig brain
DNA was run in parallel for each experiment. The log of the
radioactivity hybridized to the amplified viral target/radioactivity hybridized to the amplified standard ratio was plotted
against the log of the number of viral copies per cell equivalent. To calctlate the amount of viral DNA in the unknown
samples, the same ratio was calculated for the sample and then
the number of viral genome copies per cell equivalent was
obtained by interpolation of this ratio in the titration curve.
Cross-bred PRV-free pigs (body weight, 40 lbs [18.14 kg])
from a single source, homogenous in genetics, sex, and age,
were randomly assigned to treatment groups of 10 animals
each. Two experiments were conducted, as described below.
Experiment 1. Levels of latent DNA in TG attained by
different strains. Experiment 1 was directed towards quantitating the level of colonization that can be established in
latency target tissues by different PRV strains administered via
the intranasal route, including two attenuated vaccine strains
and WT PRV. The four experimental groups, composed of 10
animals each, were as follows. One group was inoculated with
10 50% tissue culture infective doses (TCID50) of strain SG (a
genetically engineered strain with deletions in the genes that
code for glycoprotein gX, glycoprotein gI, and thymidine
kinase [phenotype, gl- gp63+ gX- TK-]) (Syntrovet, Lenexa,
Kans.). A second group was inoculated with 105 TCID50 of
strain BA (Bartha strain, a conventionally attenuated strain
with a deletion of the glycoprotein gI and gp63 genes [phenotype, gl- gp63- gX+ TK+]) (Bio-Ceutic Laboratories, St.
Joseph, Mo.), while the pigs in a third group received 107
TCID50 of strain BA. Finally, a fourth group consisted of 15
animals that were inoculated with 105 TCID50 of WT PRV

NOTES

8471

10

8

'4-4

0
04-

z
2-

0

<-5.81 -5.391

-4.60

1-3.80

-2.99

1> -1.80

Colonization level [log (viral copies/cell eq.)]
FIG. 1. Frequency distribution of the levels of colonization in TG
accomplished by several PRV strains applied intranasally. Class intervals are represented by midpoints of the colonization level range. *,
animals inoculated with strain SG, 105 TCID50; , animals inoculated
with strain BA, 105 TCID50; El, animals inoculated with strain BA, 107
TCID50; O, animals inoculated with the WT Becker strain, 105
TCID50. Animals classified in the <10-58 class interval are those in
which PRV DNA could not be detected (limit of sensitivity, approximately one viral genome copy in 1058 cell equivalents). Animals
classified in the 10-5.79-to10-5°0 class interval (midpoint, 10-5-39) are
those in which PRV DNA was detected by standard PCR but not by
the quantitative assay (limit of sensitivity, approximately one viral copy
in 105 cell equivalents).

(Becker strain) (obtained from K. Platt, College of Veterinary
Medicine, Iowa State University, Ames) by intranasal inoculation and eye instillation. Each group was kept in a separate
isolation room, under strict biocontainment management.
Only the animals inoculated with WT PRV (Becker strain)
exhibited frank clinical disease, and four of them died with
clear symptoms of pseudorabies during the acute period of the
infection. Ten of the 11 surviving animals were randomly
selected for quantitative evaluation of PRV DNA. The pigs in
the four groups were killed 37 to 43 days postinfection, and the
TG were collected and immediately frozen at -70°C.
The efficiency of colonization was found to be both dose and
strain dependent. As shown in Fig. 1, the tested vaccine strains
were less efficient in colonizing TG than was the WT PRV
Becker strain, which was able to establish colonization above
10-1.8 viral copies per cell equivalent (1 viral genome copy
every 400 cell equivalents) in all of the pigs (Fig. 1), in
agreement with values previously reported by others (28). With
strain BA applied at a higher dose (107 TCID5O), the mean
colonization level was 10- *88 viral copies per cell equivalent (1

viral genome copy per 760 cell equivalents), with 5 of 10
animals demonstrating levels of latency above 10-339 viral
copies per cell equivalent (approximately 1 viral genome copy
per 2,500 cell equivalents). When strain BA was applied at a
low dose (105 TCID50), the mean level of latent DNA was
10-4.24 (approximately 1 viral genome copy per 1.7 x 104 cell
equivalents), with 8 of 10 animals showing levels of latency that
ranged from 10-3-39 viral copies per cell equivalent (approximately 1 viral genome per 2,500 cell equivalents) to 10-50
viral copies per cell equivalent (1 viral genome copy every 105
cell equivalents) (Fig. 1). Finally, strain SG attained a mean
colonization level of 10-521 (approximately 1 viral genome
copy per 1.5 x 105 cell equivalents), with 9 of 10 animals
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exhibiting levels of latency below 10-5-0 viral copies per cell
equivalent (1 viral genome copy every 105 cell equivalents). SG
was, then, the strain that established the lowest levels of
latency of all the groups. It is important to note that for any
given viral strain, the level of colonization varied widely among
different animals (i.e., a range of 2 log units for strain BA at
either a high or a low dose) (Fig. 1), which is consistent with
the significant individual variability in latency levels established
by attenuated PRV strains that we reported previously (29).
Experiment 2. Challenge with WT PRV. In experiment 2, the
objective was to ascertain how precolonization of latency target
tissues by an attenuated vaccine quantitatively affects the
establishment of latency by superinfecting WT PRV. We
established three experimental groups (n = 10 each) representing the three previously determined (experiment 1) different levels (low, medium, and high) of precolonization of TG by
an attenuated vaccine strain. Therefore, one group of pigs was
inoculated with 105 TCID50 of strain SG, a second group of
pigs was inoculated with 105 TCID50 of strain BA, while a third
group was inoculated with 107 TCID50 of strain BA. Forty-five
days later, a serum sample was drawn from each animal and
each group was challenged with 105 TCID50 of PRV (Becker
strain) by simultaneous intranasal and conjunctival inoculation. WT PRV clearance was evaluated by periodic sampling
(swabs taken every 2 days from day 3 until day 11 postchallenge) of pharyngeal and conjunctival mucosae of all the
challenged animals in the three groups. Infectious virus
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FIG. 2. (A) Colonization of TG by WT virus in animals vaccinated
with a highly efficient colonizing vaccine. 13, animals inoculated with
strain BA (107 TCID50) and necropsied 45 days postvaccination. The
height of the bars represents the number of animals with a level of
colonization by the vaccine virus in that class interval (from Fig. 1). *,
animals inoculated with strain BA (107 TCID50), challenged 45 days
postvaccination with the WT Becker strain (105 TCID50), and necropsied 45 days postchallenge (90 days postvaccination). The height of the
bars represents the number of animals with a level of colonization by
WT virus in that class interval. (B) Colonization of TG by WT virus in
animals vaccinated with mid-range colonizing vaccine. 1i, animals
inoculated with strain BA (105 TCID50) and necropsied 45 days
postvaccination. The height of the bars represents the number of
animals with a level of colonization by the vaccine virus in that class
interval (from Fig. 1). *, animals inoculated with strain BA (105
TCID50), challenged 45 days postvaccination with the WT Becker
strain (105 TCID50), and necropsied 45 days postchallenge (90 days
postvaccination). The height of the bars represents the number of
animals with a level of colonization by the WT virus in that class
interval. (C) Colonization of TG by WT virus in animals vaccinated
with a poorly colonizing vaccine. El, animals inoculated with strain
SMG (105 TCID50) and necropsied 45 days postvaccination. The
height of the bars represents the number of animals with a level of
colonization by the vaccine virus in that range (from Fig. 1). *, animals
inoculated with strain SMG (105 TCID50), challenged 45 days postvaccination with the WT Becker strain (105 TCID50), and necropsied 45
days postchallenge (90 days postvaccination). The height of the bars
represents the number of animals with a level of colonization by the
WT virus in that range. For all panels, the class intervals <10-5- and
10-5-79 to 10-5-°° (midpoint, 10-5 3) are as described in the legend to
Fig. 1.

present in these samples was titrated by standard microtitration methods by using Reed and Muench interpolation. Clinical observation was performed daily. The three groups were
killed 37 to 40 days after challenge (about 85 days after
vaccination), serum samples were collected at the time of
killing, and the TG samples were processed as described for
the groups used in the first experiment.
Figure 2 shows the frequency distribution of the levels of
latency attained by the challenging WT virus for each group,
compared, in each case, with the levels of precolonization
attained by the vaccine strain and doses used for each group as
determined in the previous experiment (Fig. 1). A statistically
significant inverse correlation (Pearson's r = -0.577; P <
0.0001) between the levels of latency attained by each of the
precolonizing vaccine and WT strains was found for the three
groups. In 6 of the 10 pigs vaccinated with 107 TCID50 of the
Bartha strain (the best-colonizing strain), no WT viral DNA
could be detected (limit of sensitivity, approximately one viral
genome per 5 x 106 cell equivalents) (Fig. 2A). Furthermore,
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TABLE 1. Geometric means of TG precolonization levels attained
by three PRV inoculations and mean level of WT PRV colonization
established upon challenge of the three precolonized groups
(TCID50)

Mean precolonization by
preceding strain (SE)

WT PRV
SG
BA (105)
BA (107)

-5.21 (0.190)
-4.236 (0.257)

Strain

NAa
-2.88 (0.464)

Mean WT PRV colonization
after challenge (SE)

TABLE 2. Geometric means of neutralizing antibody titers
(twofold dilutions) after precolonization and at
necropsy of groups shown in Table 1a
(TCID50)

SN titer 45 days after
precolonization (SE)

SN titer at necropsy
(37-45 days postchallenge)

SG
BA (105)
BA (107)

2.1 (1.25)b
6.5 (4.63)b
9.0 (9.50)

87.24 (27.6)
142.2 (89.6)
152.9 (105.5)

Strain

>-1.80"
-1.777 (0.286)
-2.799 (0.471)
-4.281 (0.633)

a NA, not applicable.
b
Values are expressed as logs of the number of viral copies per cell equivalent.

the frequency distribution for WT virus latency levels in this
group is bimodal, which correlates with the bimodal distribution also seen for the level of latency established by the
precolonizing vaccine strain (Fig. 1 and 2A). As expected for
inverse correlation, the highest of the two modes is placed at
one side for the distribution of the vaccine strain colonization
(right) and at the opposite'side (left) for the distribution of the
WT colonization. Aihong the pigs vaccinated with the mediumrange colonizing strain (Bartha, 105 TCID50), 6 of 10 pigs had
levels of colonization by WT virus below 10-259 viral copies
per cell equivalent (approximately 1 viral genome every 400 or
more cells) but above 105 viral copies per cell equivalent
(approximately 1 viral genome per 105 or more cells) (Fig. 2B).
In this case, the frequency distribution of the level of latency
was approximately normal, with the peak in the medium range,
for both WT and vaccine strains (Fig. 1 and 2B). Finally,
among the pigs vaccinated with the poorly colonizing vaccine
(SG, 105 TCID50), 8 of 10 animals had levels of colonization
above 10-2-59 viral copies per cell equivalent (approximately 1
viral genome every 400 or less cells) (Fig. 2C).
Table 1 summarizes experiments 1 and 2 by presenting the
mean levels and standard errors for precolonization in TG
obtained by the three different vaccine precolonization treatments, as well as the WT PRV latency level attained in the TG
upon challenge. The levels of precolonization attained by the
three different vaccines increased in increments of approximately 1 log unit of colonization ranging from low (SG) to
medium (BA, 105 TCID50) to high (BA, 107 TCID50) (analysis
of variance [ANOVA] F2,27 = 12.95; P = 0.001). At the same
time, the level of colonization by WT PRV upon challenge
decreased at an equivalent rate ranging from the highly
precolonized group (BA, 107 TCID50) through the medium
(BA, 105 TCID50) to the poorly precolonized (SG) and the
control (WT only, non precolonized) groups (ANOVA F2,27 =
6.754; P = 0.004). The mean WT PRV colonization levels in
the control (nonprecolonized, WT PRV only) group and in the
poorly colonized (SG) group are apparently similar (t11 =
0.677; P = 0.512). However, it is important to observe that high
levels of colonization by a PRV strain fall out of the range of
the dose-response curve for which our quantitative PCR was
calibrated (29); therefore, if differences in colonization indeed
exist between these two groups, they would go undetected. In
summary, it can be stated that for each log unit of increase in
the attenuated-strain precolonization level in TG, there was a
1.076-log-unit decrease in the level of WT PRV latency
attained in that tissue (r = -0.577; P < 0.0001, regression F2,28
= 14.0). The levels of neutralizing antibodies, as determined by
a standard protocol (6), are shown in Table 2. Because of
significant within-group variability, differences in the neutralizing antibody titers observed among the three groups, after
precolonization and prior to WT PRV challenge, were not
significant (F2,21 = 2.566; P - 0.1). When two-way ANOVA
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(SE)

a ANOVA indicated no statistically significant differences among the three
groups (F2,21 = 2.566; P - 0.1).
bThe difference between the results for the SG and BA (105) groups is
statistically significant (F1,14 = 15.29; 0.005 > P > 0.001) as assessed by two-way
ANOVA.

was performed, only groups BA (105 TCID50) and SG differed
significantly (F1,14 = 15.29; 0.005 > P > 0.001). No significant
differences were observed among the mean neutralizing antibody titers for the three groups upon WT PRV challenge (F2,24
=0.8484; P> 0.1).
The shedding of WT PRV after challenge of the three
differently precolonized groups was quantitated by taking

conjunctival and pharyngeal swab samples of all challenged
animals at 3, 5, 7, 9, and 11 days postchallenge. As shown in
Fig. 3, there were no statistically significant differences (Fisher's test [31]) in either the amounts or the lengths of time of
viral shedding among the three treatment groups. In all cases,
differences within each group were larger than those between
groups. Daily clinical evaluation of the animals indicated no
significant clinical differences among the three groups following the challenge. All of the animals in the three groups were
well protected in comparison with the nonvaccinated group
that received an identical dose of WT PRV (Becker strain)
(group IV, experiment 1) (Fig. 1), in which most of the animals
became severely ill, with several of them (4 of 15) dying.
The results of quantitative PCR for PRV DNA clearly
reflect individual-to-individual variability in the level of latency
established by PRV strains. However, the quantitative PCR
allowed us to group and compare strains and, furthermore, to
establish correlations between the strains' distinct abilities to
colonize target tissues. The results of the challenge of precolonized groups with WT PRV provide the most significant
conclusion of this report: the higher the frequency of precolonization by a preceding (attenuated) strain in TG of one
particular group of animals, the lower the extent of latent WT
PRV colonization established in these tissues following superinfection.
One apparent way to explain the differences in WT PRV
colonization observed among the three groups would be based
on differences in the extent of peripheral replication of WT
PRV at the portal of entry and therefore more or less seeding
of WT PRV at the TG level. However, when we compare the
levels of shedding of WT PRV at the mucosal-surface level, no
significant difference in either the length or intensity of the
clearance period could be noticed among the groups (Fig. 3),
indicating that similar levels of peripheral replication of WT
PRV took place in all cases. The data on neutralizing antibody
levels indicate that in only one group (Table 2, SG group) was
the level of circulating antibodies established by the precolonization lower than in one of the other two groups (BA, 105
TCID50). This discrepancy between circulating antibody levels
and certain parameters of clinical protection against herpesvirus infections, such as viral shedding, has been well documented previously (8, 30). Interestingly, one of the six pigs that
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as described in the text. Each point is the geometric mean for 10 pigs in each group. Standard deviations for all time points for all groups were
between 0.5 and 2.2 log units. Differences among treatment groups are not statistically significant (Fisher's test) (31).
were completely protected from WT latency (Fig. 2A; group
BA, 107 TCID5O) was the one that shed the largest amount of
virus after challenge in this group. Furthermore, in analyzing
animal-by-animal viral shedding and the corresponding level of
latency established by the superinfecting WT PRV, no correlation was evident between these two parameters (r =
-0.1359; P = 0.503) (Fig. 4). In addition, we did not observe
significant clinical differences among the three groups during
the early postchallenge period, as all of the animals from the
three groups were fairly well protected. Therefore, although a
direct immunological modulation of the establishment of WT
PRV latency cannot be ruled out by these experiments,
impairment of replication at the portal of entry does not seem
to explain the differences observed in levels of colonization of
TG by WT PRV.
If the differences in establishment of WT PRV latency are
not based on differences in WT PRV replication at the primary
site of replication, it is conceivable that the blocking of WT
PRV establishment takes place at the translocation (axonal
path) or neuronal level instead. The protection against WT
latency observed in our experiments could be an example of
resistance at the level of the tissues that are the target for
latency, for which preinfection of the neurons of that tissue
with another (preceding) strain of PRV is required. The case
of ganglionar resistance we observed would then be a special
example of intracellular interference active against homologous or homotypic viruses (24). It is possible that the interference is based on some of the viral functions (especially LAT
gene activity) expressed by the interfering strain during latency
or reactivation (4, 22, 23, 25) or on some competition for
certain important cellular factors that would be essential to the
establishment and/or maintenance of neuronal latent infection
(12). The apparent occurrence of a certain threshold for
latency (which could be defined by the fact that the observed
frequency of establishment of latency above 10' viral copies
per cell equivalent [1 viral genome copy per 1,000 cells] for a
given vaccine would be somewhat equivalent to the frequency
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of protection of challenged animals from the establishment of
WT PRV latency [Fig. 1 and 2]) would be consistent with the
models that propose that only a subset of TG neurons are
capable of harboring a latent infection (14). Under these
conditions, once this susceptible subset of cells has been
latently infected by the preceding vaccine strain, they cannot
be superinfected with the WT challenging virus. Another
plausible explanation for the interference with WT PRV
colonization could be based on direct involvement of the
immune response at the level of the site of colonization, in this
case, the TG. Further studies should certainly be directed
towards addressing these points.
In this study, we have found that there is a significant inverse
correlation between the level of latency established by an
alphaherpesvirus live modified vaccine and the level of latency
established by a superinfecting WT virus in the natural host of
the infection. Therefore, modified live virus vaccines administered through routes of immunization that maximize colonization of latency target tissues may significantly decrease latency
of WT strains. The different genetic deletions of the strains
which we used have certainly influenced the different colonization abilities observed in our experiments. It has been
reported that PRV gI is an important factor in targeting the
virus to the central nervous system (2, 34) and also that
thymidine kinase is important for herpesvirus replication in
quiescent cells (i.e., neurons) (7, 21). The simultaneous deletion of the genes encoding both these factors in strain SG
should then have impaired both targeting of the virus to
neurons and viral replication in neurons, therefore explaining
the poor colonization of TG observed with this strain. It is
interesting that colonization studies conducted in our laboratory with a gI+ strain isogeneic to SG (strain SMB; Syntrovet)
(data not shown) showed that this strain has colonization
ability significantly greater than that of any of the strain-dose
combinations reported in this paper, thus not only confirming
the important role of PRV gI in targeting neural tissue but also
suggesting that gI+ attenuated PRV strains may have optimal
ability to precolonize TG and therefore to interfere with
superinfecting WT latency. Considering the results herein
reported, the ability of a vaccine to establish latency by itself
would then be a subject worth pursuing.
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